NEWS
5/8/2012 - Sutro Closes $16.5 Million Second Tranche of
Series C Financing
Read more 
1/7/2012 - Sutro Announces Newly Formed Scientific Advisory Board - Renowned Researchers James A. Wells, Ph.D., and James R. Swartz, Sc.D., to Guide Sutro's Advancing Therapeutic Pipeline...
10/17/2011 - Sutro Biopharma to Present its Biochemical Protein Synthesis Technology at BioProduction Conference 2011 in Berlin...
TRANSLATING SCIENCE
TO NOVEL BIOTHERAPEUTICS
TRANSLATING SCIENCE
TO NOVEL BIOTHERAPEUTICS
TO NOVEL BIOTHERAPEUTICS
Sutro Biopharma, Inc. has the only scalable biochemical protein synthesis platform.
Sutro Biopharma is revolutionizing biologics research and development using biochemical protein synthesis to design proteins that have been inaccessible, and even unimaginable, until now. Sutro's synthesis technology opens up opportunities to create protein therapeutics that cannot be produced using conventional methods.
Learn more!
- Corporate Presentation (PDF)
- Fact Sheet (PDF)